INCY · Incyte Corporation
AI read · Good for INCY
The AI's read
This moves Incyte's drug program forward through its partner, which has exclusive rights in China. The trial targets a disease affecting an estimated 8.2 million people there, but it has not reported results. Success and any sales remain unproven.